KRYS — Krystal Biotech
Median target
$396
calls from the last 12 months
Implied return
+16.9%
median target vs. price
Coverage
8 analysts · 11 calls
updated in the last 12 months
Consensus
7/1/0+7 net
Buy / Hold / Sell
Which analysts are behind KRYS's consensus?
See every current rating, price target and the analysts' track records for Krystal Biotech — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 8 analysts with calls on KRYS updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
KRYS elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-09-04 | Insiders | Krishnan Krish SPresident and CEO | Insider sale | 4.0K sh @ $357.57 · planned trade | $1.4M |
| 2026-09-04 | Insiders | Krishnan SumaPresident, R&D | Insider sale | 4.0K sh @ $357.57 · planned trade | $1.4M |
| 2026-09-04 | Insiders | Krishnan SumaPresident, R&D | Insider sale | 3.4K sh @ $359.39 · planned trade | $1.2M |
| 2026-09-04 | Insiders | Krishnan Krish SPresident and CEO | Insider sale | 3.4K sh @ $359.39 · planned trade | $1.2M |
| 2026-09-04 | Insiders | Krishnan Krish SPresident and CEO | Insider sale | 3.3K sh @ $356.37 · planned trade | $1.2M |
| 2026-09-04 | Insiders | Krishnan SumaPresident, R&D | Insider sale | 3.3K sh @ $356.37 · planned trade | $1.2M |
| 2026-09-04 | Insiders | Krishnan SumaPresident, R&D | Insider sale | 3.2K sh @ $358.42 · planned trade | $1.1M |
| 2026-09-04 | Insiders | Krishnan Krish SPresident and CEO | Insider sale | 3.1K sh @ $358.42 · planned trade | $1.1M |
| 2026-09-04 | Insiders | Krishnan SumaPresident, R&D | Insider sale | 2.3K sh @ $360.47 · planned trade | $836K |
| 2026-09-04 | Insiders | Krishnan Krish SPresident and CEO | Insider sale | 2.3K sh @ $360.46 · planned trade | $817K |
More: congressional trades on KRYS · insider activity · executive branch · trending